Helicobacter pylori Testing: Global Market Outlook

Report Code: PHM269A

Publish Date: Jan 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $2500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

This report provides a brief general outlook of the global market for Helicobacter pylori testing. The report discusses the current and future strategies of vendors in the H. pylori testing market, which includes various invasive and non-invasive tests used to detect H. pylori. The revenues are broken down by region and have been estimated for the five-year period from 2022 through 2027. The report also present details with respect to Helicobacter pylori testing kits.

Report Includes

  • An overview of the global market outlook for Helicobacter pylori (H. pylori) testing
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for Helicobacter pylori testing products, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for helicobacter pylori testing market in USD million terms, and corresponding market share analysis by test type, end-user, and region
  • In-depth information (facts and figures) concerning the major market dynamics, industry structure, and competitive environment of the leading market participants
  • Market outlook and assessment of the recent strategic analysis in the global helicobacter pylori testing market with emphasis on key developments
  • Company profiles of the leading industry players

Report Scope

In this report, the market has been segmented based on test type, end user, and geography. The report provides an overview of the global Helicobacter pylori testing market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period of 2022 to 2027. Market values are estimated based on the total revenue of H. pylori testing product providers.

The report covers the market for Helicobacter pylori testing for the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for Helicobacter pylori testing in 2021 and provides projections for the expected market size through 2027. The scope of the study includes Helicobacter pylori testing products that are already available in the market as well as future prospects.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $551.2 million
Market size forecast $851.4 million
Growth rate CAGR of 7.5% from 2022 to 2027
Units considered $ Millions
Segments covered Test Type, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Key Market Drivers
  • Increasing Cases of Gastric Ulcer
  • Rising Prevalence of H. Pylori Infection in Geriatric Population
  • Growing Demand for Point-of-care Testing Devices
Companies studied
ABBOTTADVACARE PHARMA
AMA-MED OYBIOMERICA
CERTEST BIOTEC SLCORIS BIOCONCEPT
DIASORIN S.P.A.JANT PHARMACAL CORP.
MERIDIAN BIOSCIENCE INC.SEKISUI DIAGNOSTICS LLC.
THERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The Helicobacter pylori testing market is projected to grow from $551.2 million in 2021 to $851.4 million in 2027, at a compound annual growth rate (CAGR) of 7.5% during the forecast period.
The key factors driving the growth of Helicobacter pylori testing market includes: • Increasing Cases of Gastric Ulcer. • Rising Prevalence of H. pylori infection in Geriatric Population. • Growing Demand of Point-of-care Testing Device.
The Helicobacter pylori testing market is segmented based on test type, end user, and region.
Serology test segment will dominate the market by the end of 2027.
Key companies in the market includes Thermo Fisher Scientific, DiaSorin S.p.A., Abbott, Meridian Bioscience, Inc., Biomerica, Inc.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Helicobacter pylori Testing: Global Market Outlook38Free

Related Reports

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

Published - Nov 2021 | Publisher - BCC Publishing | Code - BIO145B

The U.S. biodefense-related rapid pathogen identification and treatment market should reach $518.3 million by 2026 from $366.3 million in 2021 at a compound annual growth rate (CAGR) of 7.2% for the forecast period of 2021 to 2026.

Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets

Published - Oct 2015 | Publisher - Usha Nagavarapu | Code - HLC174A

The global gastric cancer diagnostic/screening and treatment market was $235.5 billion in 2014. This market is expected to grow from $241.7 billion in 2015 to nearly $318.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.7%.

Recent Reports

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Excipients in Pharmaceuticals: Global Markets to 2029

Published - Sep 2024 | Publisher - Gundreddy Gopinadh | Code - PHM010M

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

Antibody-Drug Conjugates: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - PHM161C

The global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Published - Aug 2024 | Publisher - BCC Publishing | Code - PHM043J

The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.

Global Markets for Drug-Device Combinations

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM045F

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Gene Editing Therapeutics Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO259A

The report provides an overview of current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also include company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Helicobacter pylori Testing: Global Market Outlook
Sample Report